Efficacy of infliximab in refractory pou
✍
Marc Ferrante; Geert D'Haens; Olivier Dewit; Filip Baert; Jan Holvoet; Karel Geb
📂
Article
📅
2010
🏛
John Wiley and Sons
🌐
English
⚖ 244 KB
👁 2 views
Background: Up to 25% of inflammatory bowel disease (IBD) patients undergoing surgery with an ileal pouch-anal anastomosis (IPAA) will develop chronic pouchitis not responding to antibiotics. In case reports, thiopurine analogs and infliximab (IFX) have been proposed as effective therapy in this set